Your browser doesn't support javascript.
loading
MicroRNA editing facilitates immune elimination of HCMV infected cells.
Nachmani, Daphna; Zimmermann, Albert; Oiknine Djian, Esther; Weisblum, Yiska; Livneh, Yoav; Khanh Le, Vu Thuy; Galun, Eithan; Horejsi, Vaclav; Isakov, Ofer; Shomron, Noam; Wolf, Dana G; Hengel, Hartmut; Mandelboim, Ofer.
Afiliação
  • Nachmani D; The Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine, The Hebrew University Hadassah Medical School, Jerusalem, Israel.
  • Zimmermann A; Department of Virology, Institute for Medical Microbiology and Hygiene, Albert-Ludwigs-Universitat, Freiburg, Germany.
  • Oiknine Djian E; Virology Unit, Hadassah Hospital, The Hebrew University Hadassah Medical School, Jerusalem, Israel.
  • Weisblum Y; Virology Unit, Hadassah Hospital, The Hebrew University Hadassah Medical School, Jerusalem, Israel.
  • Livneh Y; Department of Neurobiology, Institute of Life Sciences, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Givat Ram, Jerusalem, Israel.
  • Khanh Le VT; Institute for Virology of the University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Galun E; Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Horejsi V; Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
  • Isakov O; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Shomron N; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Wolf DG; Virology Unit, Hadassah Hospital, The Hebrew University Hadassah Medical School, Jerusalem, Israel.
  • Hengel H; Department of Virology, Institute for Medical Microbiology and Hygiene, Albert-Ludwigs-Universitat, Freiburg, Germany.
  • Mandelboim O; The Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine, The Hebrew University Hadassah Medical School, Jerusalem, Israel.
PLoS Pathog ; 10(2): e1003963, 2014 Feb.
Article em En | MEDLINE | ID: mdl-24586166
ABSTRACT
The human cytomegalovirus (HCMV) is extremely prevalent in the human population. Infection by HCMV is life threatening in immune compromised individuals and in immune competent individuals it can cause severe birth defects, developmental retardation and is even associated with tumor development. While numerous mechanisms were developed by HCMV to interfere with immune cell activity, much less is known about cellular mechanisms that operate in response to HCMV infection. Here we demonstrate that in response to HCMV infection, the expression of the short form of the RNA editing enzyme ADAR1 (ADAR1-p110) is induced. We identified the specific promoter region responsible for this induction and we show that ADAR1-p110 can edit miR-376a. Accordingly, we demonstrate that the levels of the edited-miR-376a (miR-376a(e)) increase during HCMV infection. Importantly, we show that miR-376a(e) downregulates the immune modulating molecule HLA-E and that this consequently renders HCMV infected cells susceptible to elimination by NK cells.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Adenosina Desaminase / Edição de RNA / Infecções por Citomegalovirus / MicroRNAs Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Adenosina Desaminase / Edição de RNA / Infecções por Citomegalovirus / MicroRNAs Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article